Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Ultimovacs ULTIO Mar 4, 2021 75.80 0.00   
 Umida B UMIDAB Mar 4, 2021 5.06 +2.02   
 Unibap UNIBAP Mar 4, 2021 35.50 +2.60   
 Unlimited Travel Group UTG Mar 4, 2021 9.25 -1.07   
 Upsales Technology UPSALE Mar 4, 2021 69.80 +0.87   
 Urb-it URBIT Mar 4, 2021 2.68 0.00   
 Vadsbo Switchtech VADS Mar 4, 2021 4.24 -7.42   
 VBG Group B VBGB Mar 4, 2021 167.50 -0.59   
 VEF VEFLSDB Mar 4, 2021 3.83 0.00   
 Veg of Lund VOLAB Mar 4, 2021 9.28 +1.75   
 Veidekke VEIO Mar 4, 2021 107.00 0.00   
 Veoneer VNESDB Mar 4, 2021 222.20 -4.88   
 Vertiseit B VERTB Mar 4, 2021 16.55 -5.97   
 Veteranpoolen B VPABB Mar 4, 2021 25.60 +3.23   
 VibroSense Dynamics B VSDB Mar 4, 2021 8.54 +2.64   
 Vicore Pharma Holding VICO Mar 4, 2021 29.60 -2.95   
 Viking Supply Ships B VSSABB Mar 4, 2021 53.60 -1.11   
 Vindico Group VSEC Mar 4, 2021 1.78 -1.11   
 Vistin Pharma VISTNO Mar 4, 2021 17.00 0.00   
 Vitec Software Group B VITB Mar 4, 2021 409.50 +1.24   
 Vitrolife VITR Mar 4, 2021 265.40 -1.04   
 VNV Global VNV Mar 4, 2021 105.00 -2.42   
 Volati VOLO Mar 4, 2021 107.60 -1.65   
 Volati Pref VOLOPREF Mar 4, 2021 650.00 +0.31   
 Volvo A VOLVA Mar 4, 2021 225.50 -0.66   
 Volvo B VOLVB Mar 4, 2021 225.10 -0.57   
 Vow VOWO Mar 4, 2021 50.00 0.00   
 Västsvensk Logistik VASLOG Mar 4, 2021 71.50 0.00   
 Wallenius Wilhelmsen WAWIO Mar 4, 2021 24.60 0.00   
 Wallenstam B WALLB Mar 4, 2021 118.90 +0.17   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK